Síndrome de Hedinger secundario a tumor neuroendocrino ileal

  1. Martín García, Ana 1
  2. Martín García, Agustín C. 1
  3. Navarro, Miguel 2
  4. Díaz Peláez, Elena 1
  5. Sánchez, Pedro L. 1
  1. 1 Servicio de Cardiología. Hospital Universitario de Salamanca. IBASAL-CIBER CV. Salamanca. España
  2. 2 Servicio de Oncología. Hospital Universitario de Salamanca. Salamanca. España
Revista:
Revista de Ecocardiografía práctica y otras Técnicas de Imagen Cardíaca (RETIC)

ISSN: 2529-976X

Ano de publicación: 2018

Título do exemplar: Journal of Practical Echocardiography and Other Cardiac Imaging Techniques

Volume: 1

Número: 1

Páxinas: 51-54

Tipo: Artigo

DOI: 10.37615/RETIC.V1N1A12 DIALNET GOOGLE SCHOLAR lock_openAcceso aberto editor

Outras publicacións en: Revista de Ecocardiografía práctica y otras Técnicas de Imagen Cardíaca (RETIC)

Resumo

We present a case of Hedinger syndrome or cardiomyopathy due to metastatic carcinoid tumor of special educational interest because it allows an iconographic review of the typical characteristics of valvulopathies associated with Hedinger syndrome using different imaging techniques. Hedinger syndrome in carcinoid syndrome occurs in more than half of the cases and is produced by vasoactive substances released by the carcinoid tumor that mainly affect the right heart valves (tricuspid and pulmonary) and, in up to 10% of cases, there is also damage at the level of the aortic and/or mitral valves.

Referencias bibliográficas

  • Yao JC, Hassan M, Phan A, et al. One hundred years after “carcinoid”: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. Journal of clinical oncology: Official Journal of the American Society of Clinical Oncology 2008; 26: 3.063-3.072. DOI: https://doi.org/10.1200/JCO.2007.15.4377
  • Lundin L, Norheim I, Landelius J, et al. Carcinoid heart disease: relationship of circulating vasoactive substances to ultrasounddetectable cardiac abnormalities. Circulation 1988; 77: 264-269. DOI: https://doi.org/10.1161/01.CIR.77.2.264
  • Bhattacharyya S, Toumpanakis C, Burke M, et al. Features of carcinoid heart disease identified by 2 and 3-dimensional echocardiography and cardiac MRI. Circulation Cardiovascular imaging 2010; 3: 103-111. DOI: https://doi.org/10.1161/CIRCIMAGING.109.886846
  • Plockinger U, Gustafsson B, Ivan D, et al. ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: echocardiography. Neuroendocrinology 2009; 90: 190-193. DOI: https://doi.org/10.1159/000225947
  • Luis SA, Pellikka PA. Carcinoid heart disease: Diagnosis and management. Best practice & research Clinical endocrinology & metabolism 2016; 30: 149-158. DOI: https://doi.org/10.1016/j.beem.2015.09.005
Fonte de datos: Dialnet